SCHEMBL30198653

SCHEMBL30198653

O=C(/C=C/c1ccccc1-c1cccc(/C=C/C(=O)c2ccccc2)c1-c1ccccc1/C=C/C(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 8/20 0.54
RAB9A P51151 6/20 0.54
NPC1 O15118 5/20 0.54
LMNA P02545 2/20 0.54
BCHE P06276 2/20 0.54
MAOB P27338 4/20 0.53
CYP1B1 Q16678 2/20 0.53
PLIN1 O60240 1/20 0.53
TNFRSF1A P19438 1/20 0.53
ACHE P22303 1/20 0.53
RECQL P46063 1/20 0.53
PLIN5 Q00G26 1/20 0.53
ABHD5 Q8WTS1 1/20 0.53
TYR P14679 1/20 0.50
KMT2A Q03164 4/20 0.48
ALDH1A1 P00352 4/20 0.48
HPGD P15428 4/20 0.48
NFKB1 P19838 3/20 0.48
NFKB2 Q00653 3/20 0.48
RELA Q04206 3/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL29569445 0.91 MAPT (0.62) MAPTRAB9ANPC1LMNABCHE
SCHEMBL28140891 0.84 MAPT (0.51) MAPTRAB9ANPC1LMNABCHE
SCHEMBL28812854 0.83 BCHE (0.60) MAPTRAB9ANPC1LMNABCHE
SCHEMBL9240254 0.83 MAPT (0.57) MAPTRAB9ANPC1LMNABCHE
SCHEMBL9240252 0.83 MAPT (0.57) MAPTRAB9ANPC1LMNABCHE
SCHEMBL17541840 0.83 MAPT (0.61) MAPTRAB9ANPC1LMNABCHE
SCHEMBL17541845 0.83 MAPT (0.61) MAPTRAB9ANPC1LMNABCHE
SCHEMBL9664021 0.82 MAPT (0.60) MAPTRAB9ANPC1LMNABCHE
SCHEMBL27969001 0.82 MAPT (0.60) MAPTRAB9ANPC1LMNABCHE
SCHEMBL9006476 0.82 MAPT (0.69) MAPTRAB9ANPC1LMNABCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11565235-B2 System and method for removing contaminants YOUNGSTOWN STATE UNIVERSITY (US) 2023-01-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11565235-B2 System and method for removing contaminants RIF1, ATF1, MUS81 MAPT 1858/4885RAB9A 4377/4885NPC1 2650/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.